Johanna Mercier Gilead Sciences, Inc. (GILD) insider trading activity

Johanna Mercier is Chief Commercial Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 75,140 shares of GILD, which is worth approximately $6.96 Million. The most recent transaction as insider was on Dec 10, 2024, when has been sold 1,739 shares (Common Stock) at a price of $92.34 per share, resulting in proceeds of $160,579. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.1K

3.82% 3M change

17.4% 12M change

Total Value Held $6.96 Million

Johanna Mercier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2024	SELL Payment of exercise price or tax liability	$160,579 $92.34 p/Share	1,739 Reduced 2.26%	75,140 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	3,752 Added 4.65%	76,879 Common Stock
Nov 06 2024	SELL Open market or private sale	$456,400 $91.28 p/Share	5,000 Reduced 6.4%	73,127 Common Stock
Sep 12 2024	SELL Open market or private sale	$2,458,355 $83.74 p/Share	29,357 Reduced 27.31%	78,127 Common Stock
Sep 10 2024	SELL Payment of exercise price or tax liability	$141,216 $81.44 p/Share	1,734 Reduced 1.59%	107,484 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	-	3,752 Added 3.32%	109,218 Common Stock
Aug 28 2024	SELL Open market or private sale	$742,299 $78.03 p/Share	9,513 Reduced 8.27%	105,466 Common Stock
Aug 13 2024	SELL Open market or private sale	$406,150 $73.98 p/Share	5,490 Reduced 4.56%	114,979 Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$111,838 $65.25 p/Share	1,714 Reduced 1.4%	120,469 Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	-	3,751 Added 2.98%	122,183 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$342,472 $75.12 p/Share	4,559 Reduced 3.71%	118,432 Common Stock
Mar 10 2024	BUY Exercise of conversion of derivative security	-	9,844 Added 7.41%	122,991 Common Stock
Jan 31 2024	SELL Payment of exercise price or tax liability	$1,761,554 $78.26 p/Share	22,509 Reduced 16.59%	113,147 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	74,055 Added 35.31%	135,656 Common Stock
Jan 09 2024	SELL Open market or private sale	$702,465 $85.23 p/Share	8,242 Reduced 9.06%	82,729 Common Stock
Dec 10 2023	SELL Payment of exercise price or tax liability	$98,537 $79.02 p/Share	1,247 Reduced 1.35%	90,971 Common Stock
Dec 10 2023	BUY Exercise of conversion of derivative security	-	2,730 Added 2.88%	92,218 Common Stock
Sep 10 2023	SELL Payment of exercise price or tax liability	$95,456 $76.0 p/Share	1,256 Reduced 1.38%	89,488 Common Stock
Sep 10 2023	BUY Exercise of conversion of derivative security	-	2,730 Added 2.92%	90,744 Common Stock
Jul 24 2023	SELL Payment of exercise price or tax liability	$246,492 $77.66 p/Share	3,174 Reduced 6.16%	48,326 Common Stock
Jul 24 2023	BUY Exercise of conversion of derivative security	-	7,505 Added 12.72%	51,500 Common Stock
Jun 10 2023	SELL Payment of exercise price or tax liability	$99,368 $78.12 p/Share	1,272 Reduced 2.81%	43,995 Common Stock
Jun 10 2023	BUY Exercise of conversion of derivative security	-	2,730 Added 5.69%	45,267 Common Stock
Mar 10 2023	SELL Payment of exercise price or tax liability	$406,722 $79.5 p/Share	5,116 Reduced 5.86%	82,225 Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	-	10,976 Added 11.16%	87,341 Common Stock

Also insider at

NBIX

NEUROCRINE BIOSCIENCES INC Healthcare

Director

Johanna Mercier

Chief Commercial Officer

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account